|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
The Baruch Padeh Medical Center, Poriya |
| Information provided by: | The Baruch Padeh Medical Center, Poriya |
| ClinicalTrials.gov Identifier: | NCT00329316 |
Purpose
To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent.
| Condition | Intervention |
|
Pregnancy Premature Birth |
Drug: Crinone Gel 8% |
| ChemIDplus related topics: | Progesterone |
| Study Type: | Interventional |
| Study Design: | Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study |
Eligibility
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Pregnancy 24 weeks' gestation Preterm labor in previous pregnancies
-
Exclusion Criteria:
Contacts and Locations| The Baruch Padeh Medical Center, Poriya |
| Study Chair: | Yuri Perlitz, MD | The Baruch Padeh Medical Center, Poriya |
| Principal Investigator: | Mosheh Ben Ami, Prof. | Head of Obs/Gyn ,The Baruch Padeh Medical center, Poriya |
More Information
| Study ID Numbers: | PTL Progesterone Perlitz.CTIL |
| First Received: | May 23, 2006 |
| Last Updated: | June 26, 2008 |
| ClinicalTrials.gov Identifier: | NCT00329316 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
|
|
|
|